YEAR: 2007
A World of Possibilities
8th International Congress Autism Europe
31st August – 2nd September 2007 , Oslo
Clinical Expert Forum» AMEA/CEE/EMS Group A
sponsored by Eli Lilly
30th November – 1st December 2007 ,
Clinical Expert Forum» AMEA/CEE/EMS Group B
sponsored by Eli Lilly
30th November – 1st December 2007 ,
Masterclass on
“Seizures and Epilepsy in the Elderly”
28th -29th March 2008, Mainz
‘Lennox-Gastaut Syndrome: Old Challenges, New Solutions’
Eisai satellite symposium at the EPNS
28th September 2007, Kusadasi, Turkey
«Long Term Treatment of Bipolar Disorders & Schizophrenia: A Focus on Relapse Prevention»
Meeting sponsored by Eli Lilly
27th-28th April, 2007, Vienna
Developments and directions in ADHD: Sharing knowledge and ideas across Europe educational symposium supported by Janssen-Cilag
26th August, 2007, Florence
ADHD Regional Medical Conference
organised by Eli Lilly and Company
24 August 2007, Florence
Epilepsy Summit
23rd – 24th June 2007 , St Petersburg
8th International Psychiatry Forum - Mind Matters
Organised by sanofi-aventis
Bucharest, 22-23 June 2007, Bucharest
“Understanding Depression: From Neurobiology to Clinical Practice”
An educational conference supported by
Eli Lilly and Company & Boehringer Ingelheim
21–23 June 2007, Lisbon, Portugal
THE SPECTRUM OF EPILEPSIES: BROADENING HORIZONS
21st–22nd September2007, Amsterdam
Prioritising the patient: continuing progress in psychiatric care,
Stand Alone Meeting organised by AstraZeneca
Meet the expert workshop
19-21 February 2007, Valencia, Spain,
Prioritising the patient: continuing progress in psychiatric care,
Stand Alone Meeting organised by AstraZeneca
19-21 February 2007, Valencia, Spain,
‘Tolerability of atypical antipsychotics: recent controversies and future management’
Satellite symposium supported by an unrestricted educational grant from Bristol-Myers Squibb Company / Otsuka Pharmecutical Co., Ltd. at the 20thECNP Congress
17 October 2007, Vienna
‘Interface between animal research and daily clinic –the challenges for scientists and clinicians’
Satellite symposium supported by an unrestricted educational grant from H. LundbeckA/S at the 20th ECNP Congress
17 October 2007, Vienna
‘Can we further improve atypical antipsychotics?’
Satellite symposium supported by an unrestricted educational grant from Janssen-Cilag at the 20th ECNP Congress
16 October 2007, Vienna
‘The other face of depression, apathy and anhedonia: the role of noradrenaline and dopamine in causation and care’
Satellite symposium supported by an unrestricted educational grant from GlaxoSmithKline at the 20th ECNP Congress
16 October 2007, Vienna
‘Bipolar Disorders: Continued Challenges, New Vistas’
Satellite symposium supported by an unrestricted educational grant from Eli Lilly and Company at the 20th ECNP Congress
16 October 2007, Vienna
‘Treatment of schizophrenia: towards a comprehensive approach’
Satellite symposium supported by an unrestricted educational grant from Organon International at the 20th ECNP Congress
16 October 2007, Vienna
‘Changingthe focus in psychiatricillness:
treatmentof the wholeperson’
Closedmeeting supportedby an unrestrictededucationalgrantfromAstraZeneca
15 October 2007, Vienna
‘Long-Term Outcomes in Schizophrenia: Reassessing Our Clinical Expectations’
Satellite symposium supported by an unrestricted educational grant from Eli Lilly and Company at the 20th ECNP Congress
15 October 2007, Vienna
‘Paving the way to remission: the melatonergic approach in depression ’
Satellite symposium supported by an unrestricted educational grant from Servier at the 20th ECNP Congress
15 October 2007, Vienna
‘The lifelong impact of ADHD’
Satellite symposium supported by an unrestricted educational grant from Janssen-Cilag EMEA a division of Janssen Pharmaceutica NV the occasion of the 20th ECNP Congress
15 October 2007, Vienna
From bipolar disorder to schizophrenia: The spectrum of
differential diagnoses, clinical cases & management strategies
Satellite symposium on the occasion of the 20th ECNP Congress
supported by an unrestricted educational grant from
sanofi-aventis
15 October 2007, Vienna
‘From bipolar disorder to schizophrenia: The spectrum of differential diagnoses, clinical cases & management strategies’
Satellite symposium on the occasion of the 20th ECNP Congress supported by an unrestricted educational grant from sanofi-aventis
15th October 2007, 16:45–18:30, Vienna
‘Challenges in the management of behavioural problems in Alzheimer’s disease’
Satellite symposium supported by an unrestricted educational grant from Lundbeck A/S and Merz Pharmaceuticals GmbH at the 20th ECNP Congress
14 October 2007, Vienna
‘A patient perspective on schizophrenia treatment’
Satellite symposium supported by an unrestricted educational grant from Janssen-Cilag Pharma GmbH at the 20th ECNP Congress
14 October 2007, Vienna
‘Challenges in the diagnosis and management of neuropsychiatric and somatic comorbidities in generalised anxiety disorder: weighing the range of therapeutic options’
Satellite symposium supported by an unrestricted educational grant from Pfizer Pharmaceuticals Group at the 20th ECNP Congress
14 October 2007, Vienna
‘Addressing Depression: From Receptor to Remission’
Satellite symposium supported by an unrestricted educational grant from Eli Lilly and Company and Boehringer Ingelheim on the occasion of the 20th ECNP Congress
14 October 2007, Vienna
20th Congress of the European College of Neuropsychopharmacology
13-17 October 2007, Vienna
‘Breaking the barriers to effective treatment in depression: an expert roundtable debate and discussion’
Satellite symposium supported by an unrestricted educational grant from Wyeth Pharmaceuticals at the 20th ECNP Congress
13 October 2007, Vienna
Balancing Efficacy and Adverse Events: Optimal Dosing Of Atypical Antipsychotics
Satellite symposium supported by an unrestricted educational grant from Pfizer Inc. at the 20thECNP Congress
13 October 2007, Vienna
‘Finding the balance in bipolardisorders: focus on mania –efficacyand safety’
Satellite symposium supportedby an unrestrictededucationalgrantfromBristol-Myers Squibb atthe 20th ECNP Congress
13 October 2007, Vienna
‘Patient monitoring in schizophrenia –improving outcome’
Satellite symposium supported by an unrestricted educational grant from H. Lundbeck A/S at the 20thECNP Congress
13 October 2007, Vienna
‘Diagnosis, treatment and receptors: the keys to patient recovery in mood disorders’
Satellite symposium supported by an
unrestricted educational grant from Astra Zeneca
at the 20thECNP Congress
13 October 2007, Vienna
‘From circadian rhythm disorders to psychiatric diseases’
Satellite symposium supported by an unrestricted educational grant from Servier at the 20th ECNP Congress
13 October 2007, Vienna
‘Optimizing the long-term outcome of schizophrenia treatment’
Satellite symposium supported by an unrestricted educational grant from Janssen-Cilag at the 20th ECNP Congress
13 October 2007, Vienna
5th UCB Narcolepsy Masterclass
October 13th 2007,
«Drug Treatment of Depression: a Clinical Expert Meeting»
March 9-10, 2007 , Zurich
Drug Treatment of Depression: a Clinical Expert Meeting
March 9-10, 2007 , Zurich
Latest Developments in the Management and
Treatment of Diabetic Peripheral Neuropathic Pain
An educational conference supported by
Eli Lilly and Company & Boehringer Ingelheim
8th to 10th November 2007, Stockholm, Sweden
Latest Developments in the Management and
Treatment of Diabetic Peripheral Neuropathic Pain
An educational conference supported by
Eli Lilly and Company & Boehringer Ingelheim
8th to 10th November 2007, Stockholm, Sweden
Major Depressive Disorder: Plotting the Course to Remission
A Medical Conference sponsored by Eli Lilly and Boehringer Ingelheim
November 7th, 2007, Stockholm
International Schizophrenia Expert Meeting
From pharmacology through clinical studies to patient outcomes
6th – 7th September 2007 , Istanbul
Lundbeck stand-alone symposium
“Different populations – different needs?!”
5th April 2008, Budapest
MasterClass – New Onset Epilepsy
4th – 5th May 2007, Paris
B:MasterClass – New Onset Epilepsy
4th – 5th May 2007, Paris
‘Treatment needs and solutions as seen by different players in the ADHD field’
Satellite Symposium
4th June 2007, Würzburg, Germany
Living with schizophrenia: beyond acute
symptom control
An international meeting of minds
supported by AstraZeneca
Meet-the-Expert Workshop
3-5 March 2008, Athens, Greece
Understanding current treatments and future directions
educational symposium supported by Janssen-Cilag
3rd June, 2007, Würtzburg
Living with schizophrenia: beyond acute symptom control
An international meeting of minds
supported by AstraZeneca
3-5 March 2008, Athens, Greece